VACCIMEL, an allogeneic melanoma vaccine, efficiently triggers T cell immune responses against neoantigens and alloantigens, as well as against tumor-associated antigens - Carri, Ibel; Schwab, Erika; Trivino, Juan Carlos; von Euw, Erika M.; Nielsen, Morten; Mordoh, José; Barrio, María Marcela (Frontiers in Immunology, 2025)